Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel L Aitken

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|March 27, 2020
Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the ResultsNicolo L Cabrera, Alexandre E Malek, Samuel L Aitken, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
New antifungals for the treatment of invasive mold diseaseNancy N Vuong, David R McClung, Samuel L Aitken, et al.
Pharmacotherapy|March 9, 2016
Agricultural Applications for Antimicrobials. A Danger to Human Health: An Official Position Statement of the Society of Infectious Diseases PharmacistsSamuel L Aitken, Thomas J Dilworth, Emily L Heil, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus AmpicillinSamira Dahesh, Brian Wong, Victor Nizet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2013
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, tooJerry Altshuler, Samuel L Aitken, David Guervil, et al.
Journal of Intensive Care Medicine|November 23, 2017
Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill PatientsTeresa Poon, Daryl Glick Paris, Samuel L Aitken, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2018
Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a reviewFarnaz Foolad, Brandie D Taylor, Samuel A Shelburne, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2017
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 CoursesFrank P Tverdek, Sang Taek Heo, Samuel L Aitken, et al.
American Journal of Infection Control|May 9, 2015
Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010Jacqueline R Argamany, Samuel L Aitken, Grace C Lee, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Activity of Cefiderocol and Comparators against Isolates from Cancer PatientsKenneth V I Rolston, Baghat Gerges, Samuel Shelburne, et al.
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|March 27, 2020
Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the ResultsNicolo L Cabrera, Alexandre E Malek, Samuel L Aitken, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 9, 2026
New antifungals for the treatment of invasive mold diseaseNancy N Vuong, David R McClung, Samuel L Aitken, et al.
Pharmacotherapy|March 9, 2016
Agricultural Applications for Antimicrobials. A Danger to Human Health: An Official Position Statement of the Society of Infectious Diseases PharmacistsSamuel L Aitken, Thomas J Dilworth, Emily L Heil, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2019
Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus AmpicillinSamira Dahesh, Brian Wong, Victor Nizet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2013
Treatment of extended-spectrum Beta-lactamase enterobacteriaceae with cefepime: the dose matters, tooJerry Altshuler, Samuel L Aitken, David Guervil, et al.
Journal of Intensive Care Medicine|November 23, 2017
Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill PatientsTeresa Poon, Daryl Glick Paris, Samuel L Aitken, et al.
The Journal of Antimicrobial Chemotherapy|March 17, 2018
Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a reviewFarnaz Foolad, Brandie D Taylor, Samuel A Shelburne, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2017
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 CoursesFrank P Tverdek, Sang Taek Heo, Samuel L Aitken, et al.
American Journal of Infection Control|May 9, 2015
Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010Jacqueline R Argamany, Samuel L Aitken, Grace C Lee, et al.
Antimicrobial Agents and Chemotherapy|February 20, 2020
Activity of Cefiderocol and Comparators against Isolates from Cancer PatientsKenneth V I Rolston, Baghat Gerges, Samuel Shelburne, et al.
Pageof 11